MedTrace Logo

Study of Chokeberry to Reduce Cardiovascular Disease Risk in Former Smokers

NCT01541826 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 62

Last updated 2017-07-11

Study results available
· View outcomes & findings →

Summary

The purpose of this project is to determine whether chokeberry polyphenols mitigate cardiovascular disease risk in former smokers.

Conditions

Interventions

DIETARY_SUPPLEMENT

Chokeberry Extract

Consumption of 2 x 250 mg chokeberry extract capsules daily for 12 weeks.

DIETARY_SUPPLEMENT

Placebo capsule

Color-matched rice powder pill, 2 x 250 mg/day for 12 weeks

DIETARY_SUPPLEMENT

Chokeberry extract capsule, acute

Chokeberry extract capsule, 2 x 250 mg, one-time dose.

Sponsors & Collaborators

  • University of Connecticut

    lead OTHER

Principal Investigators

  • Bradley W Bolling, PhD · University of Connecticut, University of Wisconsin-Madison

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-02-29
Primary Completion
2015-08-31
Completion
2016-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01541826 on ClinicalTrials.gov